Ann: Investor Conference Call, page-12

yeah. Tony did a pretty good job

(1)It seems this cost them next to nothing and they should be able to charge much more than $10 considering a lab test is up to $5,000 and an at home test is up to $500. (My guess is somewhere in the $50 - $100 range, considering Resmed have a $17b business selling CPAP machines and 80% of sleep apnoea sufferers are diagnosed - I think that is achievable and I also think Resmed, Phillips and Medtronic will all be interested)

(2) They have been working on this for some time and now believe they have a platform technology.
- First Asthma and Pneumonia in kids
-... which grew to include Bronciolitis, URTI and Croup
-Then strong indications in Asthma, Pneumonio, COPD in Adults
-Then indications to MANAGE COPD and Asthma in Adults
-Now potentially disruptie indications in Sleep Apnoea - which they hope to file for regulatory submission this year.

and they said they continue to work on leveraging their platform into other areas!

Hopefully this is the gift that keeps on giving with what seems like scope for a lot of news flow this year and into the next